Company news

Keros Therapeutics, Inc. news in 2023

Keros Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition

December 10, 2023

Keros Therapeutics to Present at Upcoming Healthcare Conferences

November 6, 2023

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results

November 5, 2023

Keros Therapeutics to Present at the 65th American Society of Hematology Annual Meeting and Exposition

November 1, 2023

Keros Therapeutics Presents Preclinical Data from its KER-065 Program at the 28th International Annual Congress of the World Muscle Society

October 3, 2023

Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results

August 6, 2023

Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension

July 23, 2023

Keros Therapeutics Announces Update to Participation at the Goldman Sachs 44th Annual Global Healthcare Conference

June 11, 2023

Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual Congress of the European Hematology Association

June 8, 2023

Keros Therapeutics to Present at Goldman Sach’s 44th Annual Global Healthcare Conference

June 6, 2023

Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference

May 21, 2023

Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association

May 10, 2023

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2023 Financial Results

May 3, 2023

Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors

April 18, 2023

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results

March 2, 2023

Keros Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference

February 28, 2023

Keros Therapeutics to Present at the SVB Securities Global Biopharma Conference

February 6, 2023

Decks in 2023